Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1858

BioDiem Ltd (BDM) - Financial and Strategic SWOT Analysis Review

BioDiem Ltd (BDM) - Financial and Strategic SWOT Analysis Review

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $125.00
Meta Description BioDiem Ltd. (BioDiem) is a biotechnology company. The company carries out the discovery, development and commercialization of vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal a
Publisher GlobalData
Date of Report Dec 3, 2013
Quick Overview
Summary

BioDiem Ltd. (BioDiem) is a biotechnology company. The company carries out the discovery, development and commercialization of vaccines and infectious disease therapies. It develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. The company possesses Live Attenuated Influenza Virus (LAIV) technology, the SAVINE platform and two synthetic compounds, namely, BDM-E and BDM-I. LAIV technology is used for the development of a novel intranasal vaccine for pandemic and seasonal influenza.

This comprehensive SWOT profile of BioDiem Ltd provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
BioDiem Ltd - Key Facts 4
BioDiem Ltd - Key Employees 5
BioDiem Ltd - Key Employee Biographies 6
BioDiem Ltd - Key Operational Employees 7
BioDiem Ltd - Major Products and Services 8
BioDiem Ltd - Pharmaceutical Pipeline Products Data 9
BioDiem Ltd, Pipeline Products by Therapy Area 9
BioDiem Ltd, Pipeline Products by Development Phase 10
BioDiem Ltd - History 12
BioDiem Ltd - Company Statement 14
BioDiem Ltd - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 16
BioDiem Ltd - Business Description 16
BioDiem Ltd - Corporate Strategy 17
BioDiem Ltd - SWOT Analysis 18
SWOT Analysis - Overview 18
BioDiem Ltd - Strengths 18
Strength - LAIV Technology 18
Strength - Strong Research and Development Capabilities 18
Strength - Recognition by WHO 18
BioDiem Ltd - Weaknesses 18
Weakness - History of Losses 18
BioDiem Ltd - Opportunities 19
Opportunity - Partnerships and Collaborations 19
Opportunity - Emerging Markets 19
Opportunity - Changing Demographics 19
BioDiem Ltd - Threats 19
Threat - Competition 19
Threat - Industry Consolidation 19
Threat - Uncertain R&D Outcomes 20
BioDiem Ltd - Key Competitors 21
Section 3 – Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 27
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 28
BioDiem Ltd, Recent Deals Summary 29
Section 5 – Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
BioDiem Ltd, Key Facts 4
BioDiem Ltd, Key Employees 5
BioDiem Ltd, Key Employee Biographies 6
BioDiem Ltd, Key Operational Employees 7
BioDiem Ltd, Major Products and Services 8
BioDiem Ltd, Number of Pipeline Products by Therapy Area 9
BioDiem Ltd, Number of Pipeline Products by Development Stage 10
BioDiem Ltd, Pipeline Products By Therapy Area and Development Phase 11
BioDiem Ltd, History 12
BioDiem Ltd, Subsidiaries 15
BioDiem Ltd, Key Competitors 21
BioDiem Ltd, Ratios based on current share price 22
BioDiem Ltd, Annual Ratios 22
BioDiem Ltd, Interim Ratios 25
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 27
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 28
BioDiem Ltd, Recent Deals Summary 29
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List of Figures
BioDiem Ltd, Pipeline Products by Therapy Area 9
BioDiem Ltd, Pipeline Products by Development Phase 10
BioDiem Ltd, Performance Chart (2008 - 2012) 24
BioDiem Ltd, Ratio Charts 26
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 27
BioDiem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 28




...